臨床化学シンポジウム
Online ISSN : 2187-4085
Print ISSN : 0386-3417
ISSN-L : 0386-3417
B-11. 新抗癌剤: 1, 3-Bis (Tetrahydro-2-Furanyl)-5-Fluoro-2, 4-Pyrimidinedioneとその代謝産物の分離同定
中島 修福元 敦子磯田 隆子柏木 美登里松丸 英子佐中 孜早坂 勇太郎相良 正彦木下 忠雄武正 勇造都志見 隆小山 善之
著者情報
ジャーナル フリー

1978 年 17 巻 p. 126-132

詳細
抄録
The pyrimidine antimetabolite such as futorafur (FT-207) is widely prescribed in carcinomas of breast and gastrointestinal tract. Since 1972, it has been suggested that FT-207 act through metabolic conversion to 5-FU and represented a chemical depot form of 5-FU. The newly synthesized antimetabolic drug, FD-1, is lipid soluble and believed that it is converted to FT-207 and N-3 compound, respectively. These two chemicals are further converted to 5-FU as the active metabolite for cancer therapy. For the preparation of the program for the treatment of the patients with carcinomas by FD-1, it is essential to estimate the concentration of FD-1 and its metabolites in biological fluides.
A high speed liquid chromatography was developed for the separation and estimation of FD-1 and its metabolites. To solubilize FD-1 in water system, paired ion chromatographic method using PICth B7 was applied. On high speed liquid chromatogram, 5-FU, FT-207, N-3 and FD-1 were separated and eluted in this order. The determination of 5-FU with sensitivity of 1ng/ml and of FD-1 with sensitivity of 10ng/ml, respectively. The results have suggested that the method would be sufficient for the clinical studies of these anticancer therapeutics.
The effect of each drug on cellular immunity was estimated individually by means of normal human lymphocyte culture system. For this purpose, the lymphocytes were separated into T and B cells by free flow electrophoresis. The blastogenesis of T cell against each drug was carried out in the presence of phytohemaggultinin-P, and of B cell was performed in the presence of porkweed mitogen. The results suggested that FD-1 as well as FT-207 inhibited the blastogenesis of T cell in the range of 50-60%. But N-3 compound less inhibited than these two. On the other hand, N-3 compound effectively inhibited the blastogenesis of B cell. The descrepancy of the effect of N-3 compound on the blastogenesis between T cell and B cell is not known. The metabolic pathway of FD-1 in vivo and the further metabolic pathway of its metabolites must be elucidated.
著者関連情報
© 日本臨床化学会
前の記事 次の記事
feedback
Top